John W. Bristol & Co’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $85.8M | Sell |
561,837
-7,881
| -1% | -$1.21M | 1.41% | 34 |
|
|
2025
Q4 | $78.5M | Sell |
569,718
-12,005
| -2% | -$1.57M | 1.21% | 38 |
|
|
2025
Q3 | $74.6M | Sell |
581,723
-10,558
| -2% | -$1.29M | 1.18% | 39 |
|
|
2025
Q2 | $71.7M | Sell |
592,281
-1,445
| -0.2% | -$163K | 1.16% | 41 |
|
|
2025
Q1 | $66.2M | Sell |
593,726
-15,956
| -3% | -$1.7M | 1.13% | 42 |
|
|
2024
Q4 | $59.3M | Sell |
609,682
-14,027
| -2% | -$1.5M | 0.97% | 40 |
|
|
2024
Q3 | $71.7M | Sell |
623,709
-1,214
| -0.2% | -$138K | 1.15% | 40 |
|
|
2024
Q2 | $66.5M | Sell |
624,923
-13,635
| -2% | -$1.37M | 1.08% | 41 |
|
|
2024
Q1 | $61.8M | Sell |
638,558
-4,197
| -0.7% | -$430K | 1.05% | 42 |
|
|
2023
Q4 | $64.9M | Sell |
642,755
-32,654
| -5% | -$3.15M | 1.19% | 43 |
|
|
2023
Q3 | $68.8M | Sell |
675,409
-7,121
| -1% | -$723K | 1.36% | 39 |
|
|
2023
Q2 | $68.9M | Sell |
682,530
-4,491
| -0.7% | -$449K | 1.3% | 41 |
|
|
2023
Q1 | $63.2M | Buy |
687,021
+3,818
| +0.6% | +$333K | 1.3% | 38 |
|
|
2022
Q4 | $62M | Buy |
683,203
+3,537
| +0.5% | +$298K | 1.47% | 37 |
|
|
2022
Q3 | $51.7M | Sell |
679,666
-10,228
| -1% | -$848K | 1.29% | 40 |
|
|
2022
Q2 | $58.3M | Sell |
689,894
-18,724
| -3% | -$1.64M | 1.43% | 35 |
|
|
2022
Q1 | $62.2M | Sell |
708,618
-16,862
| -2% | -$1.46M | 1.23% | 41 |
|
|
2021
Q4 | $63.5M | Sell |
725,480
-8,764
| -1% | -$728K | 1.1% | 44 |
|
|
2021
Q3 | $60M | Sell |
734,244
-11,024
| -1% | -$992K | 1.12% | 44 |
|
|
2021
Q2 | $68M | Sell |
745,268
-5,776
| -0.8% | -$514K | 1.25% | 40 |
|
|
2021
Q1 | $64.2M | Sell |
751,044
-3,681
| -0.5% | -$330K | 1.31% | 41 |
|
|
2020
Q4 | $71.3M | Sell |
754,725
-1,097
| -0.1% | -$95.9K | 1.47% | 35 |
|
|
2020
Q3 | $65.7M | Buy |
755,822
+4,239
| +0.6% | +$367K | 1.49% | 32 |
|
|
2020
Q2 | $65.6M | Sell |
751,583
-16,598
| -2% | -$1.43M | 1.63% | 31 |
|
|
2020
Q1 | $63.3M | Sell |
768,181
-9,903
| -1% | -$884K | 1.97% | 27 |
|
|
2019
Q4 | $73.7M | Sell |
778,084
-2,380
| -0.3% | -$214K | 1.78% | 28 |
|
|
2019
Q3 | $67.8M | Sell |
780,464
-4,529
| -0.6% | -$407K | 1.76% | 29 |
|
|
2019
Q2 | $71.7M | Sell |
784,993
-100,379
| -11% | -$8.5M | 1.85% | 28 |
|
|
2019
Q1 | $76.3M | Sell |
885,372
-4,120
| -0.5% | -$331K | 2.05% | 25 |
|
|
2018
Q4 | $68.4M | Sell |
889,492
-52,838
| -6% | -$4.11M | 2.15% | 23 |
|
|
2018
Q3 | $72.8M | Sell |
942,330
-10,360
| -1% | -$766K | 1.92% | 27 |
|
|
2018
Q2 | $64.5M | Buy |
952,690
+2,525
| +0.3% | +$174K | 1.83% | 32 |
|
|
2018
Q1 | $68.8M | Sell |
950,165
-14,614
| -2% | -$1.11M | 1.95% | 28 |
|
|
2017
Q4 | $72.6M | Sell |
964,779
-45,855
| -5% | -$3.46M | 2.06% | 25 |
|
|
2017
Q3 | $77.7M | Sell |
1,010,634
-41,263
| -4% | -$3.12M | 2.25% | 13 |
|
|
2017
Q2 | $78.7M | Sell |
1,051,897
-130,747
| -11% | -$9.27M | 2.31% | 10 |
|
|
2017
Q1 | $78.7M | Buy |
1,182,644
+246,915
| +26% | +$16.5M | 2.17% | 17 |
|
|
2016
Q4 | $61.1M | Sell |
935,729
-33,269
| -3% | -$2.16M | 1.72% | 33 |
|
|
2016
Q3 | $68.6M | Buy |
968,998
+91,210
| +10% | +$6.65M | 1.88% | 24 |
|
|
2016
Q2 | $64.9M | Sell |
877,788
-50,181
| -5% | -$3.47M | 1.83% | 27 |
|
|
2016
Q1 | $60.2M | Sell |
927,969
-32,588
| -3% | -$2.22M | 1.63% | 36 |
|
|
2015
Q4 | $74.1M | Sell |
960,557
-26,230
| -3% | -$2.08M | 1.95% | 22 |
|
|
2015
Q3 | $81.3M | Sell |
986,787
-165,376
| -14% | -$14.7M | 2.17% | 16 |
|
|
2015
Q2 | $102M | Sell |
1,152,163
-91,169
| -7% | -$8.36M | 2.17% | 14 |
|
|
2015
Q1 | $110M | Sell |
1,243,332
-133,407
| -10% | -$11.8M | 2.2% | 15 |
|
|
2014
Q4 | $114M | Sell |
1,376,739
-36,723
| -3% | -$3.04M | 2.08% | 24 |
|
|
2014
Q3 | $119M | Sell |
1,413,462
-55,595
| -4% | -$4.5M | 2.14% | 20 |
|
|
2014
Q2 | $119M | Sell |
1,469,057
-33,249
| -2% | -$2.62M | 2.02% | 22 |
|
|
2014
Q1 | $114M | Sell |
1,502,306
-18,048
| -1% | -$1.32M | 2% | 22 |
|
|
2013
Q4 | $110M | Sell |
1,520,354
-57,908
| -4% | -$4.03M | 1.94% | 27 |
|
|
2013
Q3 | $108M | Sell |
1,578,262
-120,573
| -7% | -$7.98M | 2.03% | 22 |
|
|
2013
Q2 | $108M | Buy |
+1,698,835
| New | +$111M | 1.97% | 24 |
|
Other funds holding NVS
John W. Bristol & Co's NVS Position: Q1 2026 in Review
John W. Bristol & Co reduced its Novartis (NVS) stake by 1.4% in Q1 2026, selling an estimated $1.21M and leaving 561,837 shares worth $85.8M. The position accounts for 1.41% of the portfolio, ranked #34.
John W. Bristol & Co first reported a position in NVS in Q2 2013 and has held it in 52 quarters since. The position peaked at $119M in Q3 2014. 1,592 funds tracked by Wall St. Rank hold NVS as of Q1 2026.
- John W. Bristol & Co held 561,837 shares of Novartis worth $85.8M as of Q1 2026.
- John W. Bristol & Co sold 7,881 Novartis shares in Q1 2026, an estimated $1.21M.
- Novartis made up 1.41% of John W. Bristol & Co's portfolio in Q1 2026, its #34 holding.
- John W. Bristol & Co first reported a position in Novartis in Q2 2013 and has held it in 52 quarters since.
- John W. Bristol & Co's Novartis position peaked at $119M in Q3 2014.
- 1,592 funds tracked by Wall St. Rank held Novartis as of Q1 2026.
Based on John W. Bristol & Co's 13F filing for Q1 2026, filed 14 May 2026.